Search

everythinglearnresearchcommunity

for

Search:↓

Most women with hirsutism have mild symptoms and often experience acne, menstrual irregularities, and obesity.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

New treatments for acne scars are safer and more effective because we understand the causes better.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

The document concludes that an inherited nail condition often improves on its own, and spironolactone effectively treats acne in women.

Topical oxygen therapy may improve treatments for hair loss, acne, and chronic skin diseases with minimal side effects.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

Children with metabolic syndrome often have skin problems like dark patches, skin tags, stretch marks, infections, acne, and psoriasis, which are linked to obesity and insulin resistance.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Blue light can help treat skin conditions like eczema and acne without major side effects.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Most cases of excessive hair growth in women are caused by polycystic ovarian syndrome and are linked to higher free testosterone levels.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Eating disorders often cause skin issues, which can help in early diagnosis and treatment.

Low vitamin D levels are linked to more skin problems.

Polycystic ovary syndrome causes chronic inflammation affecting all body systems, but proper nutrition, exercise, and supplements can improve the condition.

Skin needling is a safe, effective, and affordable treatment for various skin issues and enhances other aesthetic procedures.